Thus, our hypothesis of RIOK1 acting as an SL partner in MSI-High cells bearing abnormal p53 coincides well with RIOK1′s role in RAS-mutated CRC cell lines. The gene discussed is RIOK1; the disease is colorectal carcinoma.